Abstract:
The SARS-CoV-2 virus is the infectious disease known as coronavirus disease (COVID-19), most virus-infected individual with good immune system will recover without need for special care. Meanwhile some patients will get sever infection and need consultation. Sever infection is most common in older patient and patients with chronic disease such as diabetes, hypertension, asthma and other respiratory disease, although several therapeutic strategies have been investigated, the optimal treatment approach for patients with coronavirus disease (COVID-19) remains to be elucidated. This review paper will be concentrated on antiviral drugs and role of different monoclonal antibodies in COVID-19.